Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Recurrence 1Neoplasm Metastasis 1Nasopharyngeal Carcinoma 1

Interventions

Cisplatin 51Gemcitabine 28Radiotherapy, Intensity-Modulated 26Capecitabine 19Docetaxel 16toripalimab 12Fluorouracil 11Radiotherapy 9Drug Therapy 8nedaplatin 6camrelizumab 6Induction Chemotherapy 5spartalizumab 4nimotuzumab 4Neoadjuvant Therapy 4Carboplatin 4tislelizumab 3Immune Checkpoint Inhibitors 3Chemoradiotherapy 3sintilimab 2cisplatin-guanosine adduct 2apatinib 2SSRP1 protein, human 2Radiation 2Injections 2Endostatins 2CF regimen 2streptococcal preparation 722 1penpulimab 1lobaplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Nasopharyngeal Carcinoma × 18-O-demethylcervinomycin A2 × Clear all
NCT05294172 2026-05-08

KL-A167 Injection Combined With Cisplatin and Gemcitabine vs Placebo Combined With Cisplatin and Gemcitabine in the Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

Phase 3 Active not recruiting
295 enrolled
Head & Neck

Nasopharyngeal Carcinoma, Neoplasm Metastasis, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡